Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesIntegrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs
Proceedings of the National Academy of Sciences of the United States of America, 06/26/09
Shibue T et al. - In a study to assess whether intravenously injected, nonmetastatic cancer cells cease proliferating after extravasating into the parenchyma of the lungs, these results demonstrate the critical role of integrin β1-focal adhesion kinase (FAK) signaling axis in controlling the initial proliferation of micrometastatic cancer cells disseminated in the lungs.
Methods- Development of metastases is an extended and inefficient process involving multiple steps.
- The last step involves growth of micrometastases into macroscopic tumors.
- This study tests whether intravenously injected, nonmetastatic cancer cells cease proliferating after extravasating into the parenchyma of the lungs.
- This response is attributable to the cells' inability to trigger adhesion-related signaling events when they are scattered sparsely within the extracellular matrix (ECM) of the parenchyma.
- This situation is recapitulated by culturing these nonmetastatic cells at low seeding density in ECM-derived gels in vitro, in which they undergo cell-cycle arrest resulting, in part, from insufficient activation of FAK.
- Metastatic cancer cells show sufficient FAK activation to enable their proliferation within ECM gels in vitro and continue cell-cycle progression within the lung parenchyma in vivo.
- Activation of FAK in these metastatic cells depends on expression of the β1 subunit of integrins, and proliferation of these cells after extravasation in the lungs is diminished by knocking down expression of either FAK or integrin β1.
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 10/29/09
New Advances in the Second-Line Treatment of Small Cell Lung Cancer
The Oncologist, 10/28/09
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
Journal of Clinical Oncology, 11/05/09
Sponsor
Article Search
Sponsor
Sponsor